Skip to main content
Top
Published in: Rheumatology International 6/2010

01-04-2010 | Short Communication

Behcet’s disease associated with malignancy in Korea: a single center experience

Authors: Joong Kyong Ahn, Ji Min Oh, Jaejoon Lee, Eun-Mi Koh, Hoon-Suk Cha

Published in: Rheumatology International | Issue 6/2010

Login to get access

Abstract

The aim of this study was to determine the clinical characteristics of Behcet’s disease (BD) complicated with malignancy in Korea. Of 1,769 patients with BD in our hospital, 32 patients (1.8%, 21 in solid cancer, 11 in hematologic malignancy) developed cancer. In 10 of the 32 subjects (31.3%), malignancy was diagnosed before or concomitantly with BD. Twelve cases (37.5%) occurred within the first 2 years of disease and 9 cases (28.1%) occurred 5 years after the diagnosis of BD. Myelodysplastic syndrome (MDS) was the most common disease (n = 7) followed by thyroid cancer (n = 4), breast cancer, cervix cancer, stomach cancer, rectal cancer, hepatoma, aplastic anemia (n = 3, each), renal cell cancer, endometrial cancer, lymphoma (n = 1, each). There were no significant differences in the clinical characteristic between patients with or without malignancy. Intestinal involvement were more frequent in patients with malignancy than those without, but was not statistically significant (p = 0.083). Our results demonstrate that MDS and thyroid cancer are the most common hematologic disease and solid cancer associated with BD, respectively. Further studies will be required to ascertain the pathogenic link between BD and malignancy and the prevalence of malignancy in BD.
Literature
1.
2.
3.
go back to reference Abu-Shakra M, Gladman DD, Urowitz MB (1996) Malignancy in systemic lupus erythematosus. Arthritis Rheum 39:1050–1054CrossRefPubMed Abu-Shakra M, Gladman DD, Urowitz MB (1996) Malignancy in systemic lupus erythematosus. Arthritis Rheum 39:1050–1054CrossRefPubMed
4.
go back to reference Hill CL, Zhang Y, Sigurgeirsson B, Pukkala E, Mellemkjaer L, Airio A, Evans SR, Felson DT (2001) Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet 357:96–100CrossRefPubMed Hill CL, Zhang Y, Sigurgeirsson B, Pukkala E, Mellemkjaer L, Airio A, Evans SR, Felson DT (2001) Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet 357:96–100CrossRefPubMed
5.
go back to reference Pankhurst T, Savage CO, Gordon C, Harper L (2004) Malignancy is increased in ANCA-associated vasculitis. Rheumatology (Oxford) 43:1532–1535CrossRef Pankhurst T, Savage CO, Gordon C, Harper L (2004) Malignancy is increased in ANCA-associated vasculitis. Rheumatology (Oxford) 43:1532–1535CrossRef
6.
go back to reference Cengiz M, Altundag MK, Zorlu AF, Gullu IH, Ozyar E, Atahan IL (2001) Malignancy in Behcet’s disease: a report of 13 cases and a review of the literature. Clin Rheumatol 20:239–244CrossRefPubMed Cengiz M, Altundag MK, Zorlu AF, Gullu IH, Ozyar E, Atahan IL (2001) Malignancy in Behcet’s disease: a report of 13 cases and a review of the literature. Clin Rheumatol 20:239–244CrossRefPubMed
7.
go back to reference Kural-Seyahi E, Fresko I, Seyahi N, Ozyazgan Y, Mat C, Hamuryudan V, Yurdakul S, Yazici H (2003) The long-term mortality and morbidity of Behcet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore) 82:60–76CrossRef Kural-Seyahi E, Fresko I, Seyahi N, Ozyazgan Y, Mat C, Hamuryudan V, Yurdakul S, Yazici H (2003) The long-term mortality and morbidity of Behcet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore) 82:60–76CrossRef
8.
go back to reference Kaklamani VG, Tzonou A, Kaklamanis PG (2005) Behcet’s disease associated with malignancies. Report of two cases and review of the literature. Clin Exp Rheumatol 23:S35–S41PubMed Kaklamani VG, Tzonou A, Kaklamanis PG (2005) Behcet’s disease associated with malignancies. Report of two cases and review of the literature. Clin Exp Rheumatol 23:S35–S41PubMed
9.
go back to reference Bozi E, Katoulis AC, Stavrianeas NG (2007) Association of Behcet’s disease with hematologic malignancies. Int J Dermatol 46:333–334CrossRefPubMed Bozi E, Katoulis AC, Stavrianeas NG (2007) Association of Behcet’s disease with hematologic malignancies. Int J Dermatol 46:333–334CrossRefPubMed
10.
go back to reference Criteria for diagnosis of Behcet’s disease (1990) International Study Group for Behcet’s Disease. Lancet 335:1078–1080 Criteria for diagnosis of Behcet’s disease (1990) International Study Group for Behcet’s Disease. Lancet 335:1078–1080
11.
go back to reference Kaklamani VG, Sadim M, Koumantaki Y, Kaklamanis P, Pasche B (2008) Role of polymorphisms in adamantiades—Behcet’s disease. J Rheumatol 35:2376–2378CrossRefPubMed Kaklamani VG, Sadim M, Koumantaki Y, Kaklamanis P, Pasche B (2008) Role of polymorphisms in adamantiades—Behcet’s disease. J Rheumatol 35:2376–2378CrossRefPubMed
12.
go back to reference Shin HR, Jung KW, Won YJ, Park JG, 139 KCCR-affiliated Hospitals (2004) 2002 Annual Report of the Korea Central Cancer Registry: Based on Registered Data from 139 Hospitals. Cancer Res Treat 36:103–114 Shin HR, Jung KW, Won YJ, Park JG, 139 KCCR-affiliated Hospitals (2004) 2002 Annual Report of the Korea Central Cancer Registry: Based on Registered Data from 139 Hospitals. Cancer Res Treat 36:103–114
13.
go back to reference Fain O, Hamidou M, Cacoub P, Godeau B, Wechsler B, Paries J, Stirnemann J, Morin AS, Gatfosse M, Hanslik T, Belmatoug N, Bletry O, Cevallos R, Delevaux I, Fisher E, Hayem G, Kaplan G, Le Hello C, Mouthon L, Larroche C, Lemaire V, Piette AM, Piette JC, Ponge T, Puechal X, Rossert J, Sarrot-Reynauld F, Sicard D, Ziza JM, Kahn MF, Guillevin L, Godeau P (2007) Vasculitides associated with malignancies: analysis of sixty patients [Vasculitis and neoplasms. 14 cases]. Arthritis Rheum 57:1473–1480CrossRefPubMed Fain O, Hamidou M, Cacoub P, Godeau B, Wechsler B, Paries J, Stirnemann J, Morin AS, Gatfosse M, Hanslik T, Belmatoug N, Bletry O, Cevallos R, Delevaux I, Fisher E, Hayem G, Kaplan G, Le Hello C, Mouthon L, Larroche C, Lemaire V, Piette AM, Piette JC, Ponge T, Puechal X, Rossert J, Sarrot-Reynauld F, Sicard D, Ziza JM, Kahn MF, Guillevin L, Godeau P (2007) Vasculitides associated with malignancies: analysis of sixty patients [Vasculitis and neoplasms. 14 cases]. Arthritis Rheum 57:1473–1480CrossRefPubMed
14.
go back to reference Ahn JK, Cha HS, Koh EM, Kim SH, Kim YG, Lee CK, Yoo B (2008) Behcet’s disease associated with bone marrow failure in Korean patients: clinical characteristics and the association of intestinal ulceration and trisomy 8. Rheumatology (Oxford) 47:1228–1230CrossRef Ahn JK, Cha HS, Koh EM, Kim SH, Kim YG, Lee CK, Yoo B (2008) Behcet’s disease associated with bone marrow failure in Korean patients: clinical characteristics and the association of intestinal ulceration and trisomy 8. Rheumatology (Oxford) 47:1228–1230CrossRef
15.
go back to reference Kawabata H, Sawaki T, Kawanami T, Shimoyama K, Karasawa H, Fukushima T, Masaki Y, Ogawa N, Hirose Y, Ozaki K, Shimanaka K, Takase S, Ueno H, Umehara H (2006) Myelodysplastic syndrome complicated with inflammatory intestinal ulcers: significance of trisomy 8. Int Med 45:1309–1314CrossRef Kawabata H, Sawaki T, Kawanami T, Shimoyama K, Karasawa H, Fukushima T, Masaki Y, Ogawa N, Hirose Y, Ozaki K, Shimanaka K, Takase S, Ueno H, Umehara H (2006) Myelodysplastic syndrome complicated with inflammatory intestinal ulcers: significance of trisomy 8. Int Med 45:1309–1314CrossRef
Metadata
Title
Behcet’s disease associated with malignancy in Korea: a single center experience
Authors
Joong Kyong Ahn
Ji Min Oh
Jaejoon Lee
Eun-Mi Koh
Hoon-Suk Cha
Publication date
01-04-2010
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 6/2010
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-009-1319-3

Other articles of this Issue 6/2010

Rheumatology International 6/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.